Seagen (Canada)

Seagen (Canada)

Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Seagen (Canada), Canada, covering academic research published from 2002 to 2024. Read More.


Open Access Percentage

66%


Total
Publications

87


Total Open
Publications

57


Total
Citations

6.6K


Open Access
Percentage

66%


Total
Publications

87


Total Open
Publications

57


Total
Citations

6.6K

Wikipedia

Website

download

Breakdown

28% 23% 12% 37%

Publisher Open

28%

Both

23%

Other Platform Open

12%

Closed

37%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

01234567891011Total Publications
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

38%OA Journal

OA Journal 38%

16

Hybrid 19%

8

No Guarantees 43%

18

Other Platform Open

Domain 83%

24

Institution 24%

7

Other Internet 21%

6

Preprint 3%

1

Public 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
24
DOI
Other Internet
6
Digital Access to Libraries
Institution
2
DASH - Digital Access to Scholarship at Harvard
Institution
2
University of Southern Denmark - University of Southern Denmark Research Portal
Institution
1
University of Michigan - Deep Blue
Institution
1
universiteitleiden.nl OAI-PMH Repository
Institution
1
unideb.hu OAI-PMH Repository
Institution
1
Research Square
Preprint
1
Elsevier - Scopus
Institution
1
1 / 2

Data updated 18 August 2025

Share

Share

Share